3B BlackBio Dx discusses Q2-FY26 outlook with Dalmus Capital

3B BlackBio Dx Limited, formerly Kilpest India Limited, announced the outcome of an analyst/investor meeting held with Dalmus Capital Management on Saturday, December 20, 2025. The one-on-one interaction took place in Mumbai.

The company confirmed that only information already in the public domain was discussed, and no unpublished price sensitive information was shared. The discussion reiterated information previously shared in its investor presentation for Q2-FY26, which was intimated to the stock exchanges on November 13, 2025.

Nikhil Kuber Dubey, whole time director, signed the announcement. The company also provided a web link to the presentation made to investors after the declaration of financial results for the quarter and half-year ended September 30, 2025.